Trial Profile
Phase Ib Randomized, Double-Blind, Latin Square Crossover, Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 v. Lidocaine v. Placebo in Lumbar Radiculopathy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Opiranserin (Primary) ; Lidocaine
- Indications Pain
- Focus Adverse reactions
- 16 Mar 2018 Status changed from recruiting to completed.
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.
- 04 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.